Tumor vessel co-option: The past

Overview of attention for article published in Frontiers in oncology, August 2022

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 35 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 25,624 followers.

Tumor vessel co-option: The past & the future: Tumor vessel co-option (VCO) is a non-angiogenic vascularization mechanism that is a possible cause of resistance to anti-angiogenic therapy (AAT). Multiple tumors are hypothesized to #oncology… https://t.

02 Sep 2022

Reply Repost Favourite

New research: Tumor vessel co-option: The past & the future: Tumor vessel co-option (VCO) is a non-angiogenic vascularization mechanism that is a possible cause of resistance to anti-angiogenic therapy (AAT). Multiple tumors are hypothesized to… https:

31 Aug 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.